Come up with a name for your new list and we'll add to it:
Celtaxsys raised a round of funding on June 08, 2015. Investors include
Cystic Fibrosis Foundation.
Celtaxsys is a clinical-stage pharmaceutical development company focused on advancing novel foundational therapies to treat inflammation in rare, orphan designated diseases. The company's flagship inv…